
STORM Trial Advances Selinexor + Dexamethasone for Multiple Myeloma
Author(s) -
Chuck Holt
Publication year - 2020
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000693468.87051.be
Subject(s) - daratumumab , carfilzomib , multiple myeloma , lenalidomide , dexamethasone , pomalidomide , medicine , bortezomib , refractory (planetary science) , cancer research , oncology , clinical trial , pharmacology , biology , astrobiology